Literature DB >> 29435289

Outcomes of abdominal esophageal cancer patients who were treated with esophagectomy.

Hiroyuki Kitagawa1, Tsutomu Namikawa1, Jun Iwabu1, Kazune Fujisawa1, Michiya Kobayashi2, Kazuhiro Hanazaki1.   

Abstract

The aim of the present study was to elucidate the characteristics and outcomes of abdominal esophageal cancer patients who were treated with esophagectomy. The records of 210 esophagectomy patients were retrospectively reviewed and the differences in postoperative outcomes and disease-specific survival between squamous cell carcinoma and adenocarcinoma were evaluated. Of the 20 abdominal esophageal cancer patients, 11 had squamous cell carcinoma, 8 had adenocarcinoma and 1 had adenosquamous cell carcinoma. The body mass index and serum albumin levels were significantly lower in the squamous cell carcinoma patients compared with those in the adenocarcinoma patients, and abdominal lymph node metastasis was significantly more frequent in the adenocarcinoma patients. Early recurrence occurred in 5 patients who had postoperative surgical site infection, microscopic residual cancer, and mediastinal lymph node metastasis. A Kaplan-Meier curve indicated a significantly shorter survival time in patients who underwent surgery with a thoraco-abdominal approach, who had postoperative complications, and who had microscopic residual cancer. This study demonstrated the significance of R0 resection and prevention of postoperative complications in improving the prognosis of patients with abdominal esophageal cancer.

Entities:  

Keywords:  abdominal esophageal cancer; esophagectomy; microscopic residual cancer; postoperative complications

Year:  2017        PMID: 29435289      PMCID: PMC5774478          DOI: 10.3892/mco.2017.1510

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  17 in total

1.  Association of smoking, alcohol drinking and dietary factors with esophageal cancer in high- and low-risk areas of Jiangsu Province, China.

Authors:  Ming Wu; Jin-Kou Zhao; Xiao-Shu Hu; Pei-Hua Wang; Yu Qin; Yin-Chang Lu; Jie Yang; Ai-Min Liu; De-Lin Wu; Zuo-Feng Zhang; Kok-J Frans; Pieter van 't Veer
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

Review 2.  Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment.

Authors:  Steven R DeMeester
Journal:  Ann Surg Oncol       Date:  2006-01-01       Impact factor: 5.344

3.  The Impact of Severe Anastomotic Leak on Long-term Survival and Cancer Recurrence After Surgical Resection for Esophageal Malignancy.

Authors:  Sheraz Markar; Caroline Gronnier; Alain Duhamel; Jean-Yves Mabrut; Jean-Pierre Bail; Nicolas Carrere; Jérémie H Lefevre; Cécile Brigand; Jean-Christophe Vaillant; Mustapha Adham; Simon Msika; Nicolas Demartines; Issam El Nakadi; Bernard Meunier; Denis Collet; Christophe Mariette
Journal:  Ann Surg       Date:  2015-12       Impact factor: 12.969

4.  Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

Authors:  Katrin M Sjoquist; Bryan H Burmeister; B Mark Smithers; John R Zalcberg; R John Simes; Andrew Barbour; Val Gebski
Journal:  Lancet Oncol       Date:  2011-06-16       Impact factor: 41.316

5.  A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907).

Authors:  Nobutoshi Ando; Hoichi Kato; Hiroyasu Igaki; Masayuki Shinoda; Soji Ozawa; Hideaki Shimizu; Tsutomu Nakamura; Hiroshi Yabusaki; Norio Aoyama; Akira Kurita; Kenichiro Ikeda; Tatsuo Kanda; Toshimasa Tsujinaka; Kenichi Nakamura; Haruhiko Fukuda
Journal:  Ann Surg Oncol       Date:  2011-08-31       Impact factor: 5.344

6.  Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee staging system.

Authors:  Ralf Gertler; Hubert J Stein; Rupert Langer; Marc Nettelmann; Tibor Schuster; Heinz Hoefler; Joerg-Ruediger Siewert; Marcus Feith
Journal:  Ann Surg       Date:  2011-04       Impact factor: 12.969

7.  Factors affecting cytokine change after esophagectomy for esophageal cancer.

Authors:  Akihiko Okamura; Hiroya Takeuchi; Satoru Matsuda; Masaharu Ogura; Taku Miyasho; Rieko Nakamura; Tsunehiro Takahashi; Norihito Wada; Hirofumi Kawakubo; Yoshiro Saikawa; Yuko Kitagawa
Journal:  Ann Surg Oncol       Date:  2015-01-09       Impact factor: 5.344

8.  Outcomes of thoracoscopic esophagectomy in prone position with laparoscopic gastric mobilization for esophageal cancer.

Authors:  Hiroyuki Kitagawa; Tsutomu Namikawa; Masaya Munekage; Kazune Fujisawa; Eri Munekgae; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  Langenbecks Arch Surg       Date:  2016-05-26       Impact factor: 3.445

9.  The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction.

Authors:  Nathan J Curtis; Fergus Noble; Ian S Bailey; Jamie J Kelly; James P Byrne; Timothy J Underwood
Journal:  J Surg Oncol       Date:  2013-11-14       Impact factor: 3.454

10.  The Impact of Postoperative Complications on Survivals After Esophagectomy for Esophageal Cancer.

Authors:  Eisuke Booka; Hiroya Takeuchi; Tomohiko Nishi; Satoru Matsuda; Takuji Kaburagi; Kazumasa Fukuda; Rieko Nakamura; Tsunehiro Takahashi; Norihito Wada; Hirofumi Kawakubo; Tai Omori; Yuko Kitagawa
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.